News

April 22, 2016April 23, 2016

Positive Preclinical Results for Lung Cancer Drug Announced at Annual Meeting of Cancer Research

News

ARIAD Pharmaceuticals, a pharmaceutical company dedicated to discovering innovative medicines for the improvement of cancer patients, recently presented preclinical study results of its investigational drug AP32788, a tyrosine kinase inhibitor (TKI) targeting ... Read more

April 22, 2016April 23, 2016

3M Designs an ‘Intelligent Inhaler’ System for COPD, Asthma and Other Respiratory Ills

Asthma, COPD, News

According to the World Health Organization, about 334 million individuals globally are afflicted with asthma, and 65 million suffer from moderate to severe chronic obstructive pulmonary disease (COPD) — a number expected to ... Read more

April 22, 2016May 13, 2016

CF Foundation Congratulates New Cystic Fibrosis Caucus in US Senate

Cystic Fibrosis, News

The Cystic Fibrosis Foundation represents nearly 30,000 people living with cystic fibrosis (CF) in the U.S. today. The foundation recently applauded the Senate Cystic Fibrosis Caucus initiative created by Sens. ... Read more

April 21, 2016April 21, 2016

Advances in Inhaled Drug Delivery for Lung Diseases Are Highlighted by Pulmatrix CSO

Cystic Fibrosis, News

With the growing problems caused by antimicrobial resistance, there is increased interest in the use of better strategies for drug delivery. David L. Hava, Ph.D., the chief scientific officer for Pulmatrix — a ... Read more

April 21, 2016April 21, 2016

Specific Non-small Cell Lung Cancer Patients Show Improvement in ARIAD’s Clinical Trial for Brigatinib

News

ARIAD Pharmaceuticals recently presented updated data from an ongoing Phase 1/2 trial testing brigatinib, an investigational tyrosine kinase inhibitor, in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) ... Read more

April 20, 2016April 20, 2016

Small Protein M10 Could Help Prevent Lung Fibrosis, According to Animal Study

Idiopathic Pulmonary Fibrosis, News, Scleroderma

A new study from researchers in South Carolina report that a small protein called M10 peptide might prevent fibrosis (scarring) in people with systemic sclerosis (SSc). M10 could be especially useful for ... Read more

April 20, 2016April 20, 2016

Propeller Partners with AMC to Help Asthma and COPD Patients Better Manage Their Disease

Asthma, COPD, News

Propeller Health recently announced its partnership with AMC Health to support patients with chronic obstructive pulmonary disease (COPD) and asthma to better manage their symptoms and reduce hospital emergency visits. The partnership, signed ... Read more

April 20, 2016May 13, 2016

Allergist’s Asthma Work Supported by $1.3M from Research Partners

Asthma, COPD, News

The research work of Canadian allergist and asthma researcher Harissios Vliagoftis will be funded through 2020 by $1.3 million in partnership funding from GlaxoSmithKline (GSK), the Canadian Institutes of Health Research (CIHR), and the ... Read more

April 19, 2016April 19, 2016

Increased Acidity Linked to Production of Thick, Sticky Mucus in Cystic Fibrosis

Asthma, COPD, Cystic Fibrosis, News

A research team at the University of Iowa’s Pappajohn Biomedical Institute (PBI) conducted a study on mucus abnormalities in animal models of cystic fibrosis (CF), and found that increased acidity was the ... Read more

April 19, 2016April 19, 2016

Lung Ultrasound a Possible Alternative to Chest X-ray for Pneumonia Diagnosis in Kids

News, Pneumonia

A new research study demonstrated that lung ultrasound is a novel, efficient and safe option for the diagnosis of pneumonia, representing an alternative to chest X-ray in children. The study, ... Read more